201 related articles for article (PubMed ID: 1692180)
1. Hematologic toxicity of zidovudine in HIV-infected patients.
Brogan KL; Zell SC
Am Fam Physician; 1990 May; 41(5):1521-8. PubMed ID: 1692180
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
3. [Current developments in the treatment of AIDS].
Mulder JW
Ned Tijdschr Geneeskd; 1989 Aug; 133(33):1664-6. PubMed ID: 2477718
[No Abstract] [Full Text] [Related]
4. Granulocyte-macrophage colony-stimulating factor in human immunodeficiency virus disease.
Groopman JE
Semin Hematol; 1990 Jul; 27(3 Suppl 3):8-14. PubMed ID: 2198662
[TBL] [Abstract][Full Text] [Related]
5. The use of hematopoietic hormones in HIV infection and AIDS-related malignancies.
Miles SA; Golde DW; Mitsuyasu RT
Hematol Oncol Clin North Am; 1991 Apr; 5(2):267-80. PubMed ID: 2022593
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
Hewitt RG; Morse GD
Pharmacotherapy; 1992; 12(6):455-61. PubMed ID: 1492010
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte macrophage colony stimulating factor (GM-CSF) in AIDS.
Scadden DT
Prog Clin Biol Res; 1990; 338():163-76. PubMed ID: 2189138
[TBL] [Abstract][Full Text] [Related]
8. The use of myeloid hematopoietic growth factors in patients with HIV infection.
Mitsuyasu RT; Miles SA; Golde DW
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():347-54; discussion 354-5. PubMed ID: 1691250
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic growth factors in the treatment of patients with HIV infection.
Mitsuyasu RT
Biotherapy; 1990; 2(2):173-81. PubMed ID: 1698092
[No Abstract] [Full Text] [Related]
10. Potential role of granulocyte-macrophage colony stimulating factor in patients with HIV infection.
Mitsuyasu RT; Golde DW
Behring Inst Mitt; 1988 Aug; (83):139-44. PubMed ID: 3071329
[TBL] [Abstract][Full Text] [Related]
11. Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor.
Lynch M; Yanes L; Todd K
Oncol Nurs Forum; 1988; 15(4):463-9. PubMed ID: 3041383
[No Abstract] [Full Text] [Related]
12. The clinical use of hematopoietic growth factors.
Appelbaum FR
Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
Pluda JM; Yarchoan R; Smith PD; McAtee N; Shay LE; Oette D; Maha M; Wahl SM; Myers CE; Broder S
Blood; 1990 Aug; 76(3):463-72. PubMed ID: 2198957
[TBL] [Abstract][Full Text] [Related]
14. Clinical role of granulocyte-macrophage colony-stimulating factor.
Mitsuyasu RT; Golde DW
Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
[TBL] [Abstract][Full Text] [Related]
15. Hematologic effects of AIDS therapies.
Pluda JM; Mitsuya H; Yarchoan R
Hematol Oncol Clin North Am; 1991 Apr; 5(2):229-48. PubMed ID: 1708759
[TBL] [Abstract][Full Text] [Related]
16. The use of growth hematopoietic factors in AIDS.
Groopman JE
Pathol Biol (Paris); 1992 Nov; 39(9):874-5. PubMed ID: 1371606
[No Abstract] [Full Text] [Related]
17. Clinical uses of hematopoietic growth hormones in HIV-related illnesses.
Mitsuyasu RT
AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940
[No Abstract] [Full Text] [Related]
18. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
Miles SA; Mitsuyasu RT; Moreno J; Baldwin G; Alton NK; Souza L; Glaspy JA
Blood; 1991 May; 77(10):2109-17. PubMed ID: 1709368
[TBL] [Abstract][Full Text] [Related]
19. Colony-stimulating factors in the treatment of HIV-associated non-Hodgkin's lymphoma.
Walsh C
Oncology (Williston Park); 1989 Oct; 3(10):79-83; discussion 84-6. PubMed ID: 2701212
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
Rifkin RM; Hersh EM; Salmon SE
Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]